Elitevia Consulting LLC operating out of Pensylvania USA is a specialized consulting firm dedicated to offering strategic advisory services to private equity and venture capital firms, as well as C-suite leaders in the Healthcare & Life Sciences sectors
At Elitevia, we provide specialized expertise to help Healthcare & Life Sciences companies establish industry leadership in an increasingly competitive and complex market. We work closely with C-suite executives to develop actionable strategies and plans that drive success in this evolving environment, ultimately enhancing outcomes for consumers and all key stakeholders
End-to-end strategic and operational support for Private Equity and Venture Capital firms investing in the Healthcare and life sciences sectors. Our services are designed to ensure success at every stage of the investment lifecycle, from pre-acquisition due diligence to post-acquisition optimization, delivering maximum value and return on invested capital
02
In today’s dynamic pharmaceutical & life sciences landscape, success requires tailored insights and strategies. We provide pharmaceutical & life science companies with customized analysis and guidance, offering expertise in market intelligence, regulatory insights, patient behavior analysis, forecasting, market access strategies, and market entry strategy to drive impactful decisions.
Optimizing performance is vital for sustainability and growth. We provide tailored advisory services to enhance operational efficiency, streamline supply chains, boost sales and marketing effectiveness, ensure regulatory compliance, and develop leadership for sustained success.
Sustained growth in the competitive pharmaceutical & life sciences industry demands strategic insights and agility. We help companies accelerate growth, optimize performance, and expand into new markets with expertise in market entry, product lifecycle management, M&A advisory, R&D innovation, and digital transformation.
With decades of leadership experience in the pharmaceutical and life sciences sectors, we bring unparalleled industry knowledge, strategic vision, and operational expertise. Our collaborative approach ensures that we become true partners in your investment journey, sharing your goal of maximizing value and driving transformative growth.
Pramod Yadav is a highly accomplished leader with over 37 years of experience spanning the pharmaceutical, life sciences, and specialty chemicals industries.
As the former CEO of Jubilant Pharma Ltd., a global company with over $700 million in revenue and 4,600 employees, he demonstrated exceptional leadership in managing P&L responsibilities of all the businesses, driving operational excellence, and executing strategic transformations across diverse business units, including radiopharmaceuticals, sterile injectables, Allergy Immunotherapy, Generics and APIs.
Under his guidance, the business achieved substantial growth, serving over 4 million patients annually through innovative diagnostic and therapeutic solutions. His strategic acumen has also been instrumental in securing large-scale funding, including a $150 million grant from the U.S. Department of Defense for capacity expansion and other significant financial initiatives like investments into chosen entities and then exiting with manyfold returns.
Throughout his career, Pramod has held board positions across the USA, Canada, Singapore, and India, showcasing his expertise in corporate governance, stakeholder relations, and risk management. With a proven track record of fostering innovation, optimizing operations, and building high-performing teams, he is a trusted advisor for organizations aiming to navigate complex challenges and unlock new growth opportunities in the pharmaceutical and life science sector.